Parkin Is a Component of an SCF-like Ubiquitin Ligase Complex and Protects Postmitotic Neurons from Kainate Excitotoxicity  by Staropoli, John F. et al.
Neuron, Vol. 37, 735–749, March 6, 2003, Copyright 2003 by Cell Press
Parkin Is a Component of an SCF-like Ubiquitin
Ligase Complex and Protects Postmitotic
Neurons from Kainate Excitotoxicity
specificity of substrate selection by the ubiquitination
machinery and collaborate with two other activities, a
ubiquitin-activating enzyme (E1) and a ubiquitin-conju-
gating enzyme (E2) (Hershko et al., 1983). Polyubiquitin
protein conjugates generated by this cascade are sub-
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sequently recognized and degraded by the 26S protea-Taub Institute
some complex. The parkin gene product appears to beCollege of Physicians and Surgeons
associated with ubiquitin ligase activity (Imai et al., 2000;Columbia University
Shimura et al., 2000b; Zhang et al., 2000), and it is there-15-403, 630 West 168th Street
fore tempting to hypothesize that mutations in parkinNew York, New York 10032
lead to a familial PD syndrome due to defective proteoly-2 Department of Structural Biology
sis (and consequent toxic accumulation) of parkin sub-St. Jude Children’s Research Hospital
strates.332 North Lauderdale
Prior studies have described potential parkin sub-Memphis, Tennessee 38105
strates based on interaction assays; these proteins in-
clude CDCrel-1 (Zhang et al., 2000), synphilin-1 (Chung
et al., 2001b), PAEL-R (Imai et al., 2001), and a modifiedSummary
form of -synuclein (Sp22) (Shimura et al., 2001).
-synuclein is of potential interest because mutationsMutations in parkin, which encodes a RING domain
in this gene underlie rare autosomal dominant formsprotein associated with ubiquitin ligase activity, lead
of PD (Polymeropoulos et al., 1997), and furthermore,to autosomal recessive Parkinson’s disease charac-
-synuclein protein is enriched in LBs (Spillantini et al.,terized by midbrain dopamine neuron loss. Here we
1997). All of these studies are based on the assumptionshow that parkin functions in a multiprotein ubiquitin
that such parkin-interacting proteins represent parkinligase complex that includes the F-box/WD repeat pro-
substrates. However, a number of RING proteins havetein hSel-10 and Cullin-1. HSel-10 serves to target the
been shown to function within multiprotein ubiquitin li-parkin ubiquitin ligase activity to cyclin E, an hSel-10-
gase complexes in vivo (Joazeiro and Weissman, 2000).interacting protein previously implicated in the regula-
Rbx family RING proteins (Kamura et al., 1999; Skowyration of neuronal apoptosis. Consistent with the notion
et al., 1999) function within modular, multiprotein Skp1,that cyclin E is a substrate of the parkin ubiquitin ligase
Cullin, and F-box (SCF) complexes (Patton et al., 1998;complex, parkin deficiency potentiates the accumula-
Skowyra et al., 1997). The Drosophila protein Sina andtion of cyclin E in cultured postmitotic neurons ex-
its mammalian homolog Siah-1 similarly interact withposed to the glutamatergic excitotoxin kainate and
SCF components including the F-box/WD repeat do-promotes their apoptosis. Furthermore, parkin over-
main protein Ebi, which serves to specify substrates forexpression attenuates the accumulation of cyclin E
this complex (Dong et al., 1999; Matsuzawa and Reed,in toxin-treated primary neurons, including midbrain
2001).dopamine neurons, and protects them from apoptosis.
Several lines of evidence support the notion that par-
kin functions within a multiprotein E3 complex. First,Introduction
parkin derived from cerebral cortex migrates at a dispro-
portionately large apparent molecular weight (670–418
Altered protein degradation through the ubiquitin pro-
kDa) on gel filtration chromatography (A.A., unpublished
teasome pathway (UPP) has been hypothesized to un-
data). Second, a yeast two-hybrid interaction screen for
derlie several neurodegenerative syndromes, including parkin-associated proteins indicated that the WD repeat
Parkinson’s disease (PD) (Alves-Rodrigues et al., 1998). motif constitutes a parkin-interacting module, as four
Affected neurons in sporadic PD brain, particularly do- out of ten isolated candidate clones harbored this motif
paminergic neurons in the substantia nigra, typically (data not shown). We therefore investigated whether
display ubiquitin-rich intracytoplasmic protein aggre- parkin interacts with identified SCF components, includ-
gates termed Lewy Bodies (LBs) (Lang and Lozano, ing F-box/WD repeat domain proteins. Here we show
1998). A mutation in a ubiquitin carboxy-terminal hy- that parkin associates with the previously characterized
drolase gene, uch-L1, has been linked to a rare, autoso- ubiquitin ligase components hSel-10 (also termed
mal dominant form of PD (Leroy et al., 1998). Further hCdc4, Archipelago, and Fbw7) (Koepp et al., 2001;
implicating the UPP in PD, mutations in a putative ubi- Moberg et al., 2001; Strohmaier et al., 2001; Wu et al.,
quitin ligase gene, parkin, underlie an autosomal reces- 2001) and Cullin-1 (Cul1) in an E3 complex that uses the
sive, early-onset form of Parkinson’s disease (ARPD) E2 UbcH7 to ubiquitinate target proteins. Furthermore,
(Kitada et al., 1998). Parkin harbors two RING finger we identify cyclin E, an hSel-10-interacting protein, as
motifs at its carboxyl terminus, and such RING motifs a candidate target of this complex.
are found in a number of E3 ubiquitin ligases (Joazeiro The role of cyclins is best characterized in cell cycle
and Weissman, 2000). Ubiquitin ligases control the regulation of mitotic cells, but increased cyclin activity
has been shown to trigger apoptosis of postmitotic neu-
rons (Copani et al., 2001; Liu and Greene, 2001; Padma-*Correspondence: aa900@columbia.edu
Neuron
736
nabhan et al., 1999; Park et al., 1998), and cyclins a monoclonal antibody specific for parkin protein (see
Supplementary Data at http://www.neuron.org/cgi/accumulate in postmitotic neurons in response to pro-
apoptotic stimuli such as excitotoxicity. We show that content/full/37/5/735/DC1), followed by Western blot-
ting with a polyclonal antibody against hSel-10, indi-parkin overexpression suppresses both cyclin E accu-
mulation and apoptosis in postmitotic neurons exposed cated that parkin and hSel-10 are associated (Figure
1E). In contrast, immunoprecipitation of an age-matchedto kainic acid, an excitotoxin. Furthermore, cyclin E lev-
els are elevated in parkin-deficient primary neurons, in- parkin-deficient ARPD frontal cortex extract with a par-
kin-specific monoclonal antibody failed to copurify hSel-cluding midbrain dopamine neurons, and parkin-defi-
cient brain extracts. Of note, cyclin E and additional 10. Parkin antibody immunoprecipitation of normal hu-
man frontal cortex extract (Figure 1E) or transfectedcyclins, as well as cyclin-dependent kinases (CDKs),
accumulate in a number of neurodegenerative disorders HeLa cell lysates (data not shown) failed to copurify any
form of -synuclein. Purified Flag-hSel-10, when addedincluding PD (Husseman et al., 2000; Neystat et al.,
2001). We hypothesize that parkin mutations lead to to mouse cortex extract, associated with endogenous
brain parkin in pull-down assays, whereas purified Flag-dopamine neuron loss in ARPD as a consequence of
increased susceptibility of postmitotic neurons to toxic -TrCP failed to do so (Figure 1F). As previously reported
(Strohmaier et al., 2001), tagged hSel-10 effectivelyinsults.
pulled down cyclin E as well (Figure 1F).
Results
HSel-10 Potentiates Parkin Ubiquitin Ligase Activity
We hypothesized that hSel-10 may be a component ofParkin Interacts with HSel-10, an F-Box/WD
Repeat Domain Protein a parkin-associated ubiquitin ligase complex rather than
a substrate. Consistent with this notion, we did notEpitope-tagged parkin and candidate-interacting pro-
teins were coexpressed in insect or HeLa cells, and observe parkin-dependent ubiquitination or proteolysis
of hSel-10 (data not shown). Similar to several othercomplexes were isolated by pull-down assays and sub-
sequently analyzed by Western blotting. Parkin was RING-domain ubiquitin ligases, parkin autoubiquitinates
(Zhang et al., 2000). We examined whether hSel-10 over-found to associate with hSel-10, an F-box/WD protein,
in both the HeLa cell (Figure 1A) and insect cell (Figure expression modifies parkin ubiquitin ligase activity.
Expression vectors encoding Flag-tagged wild-type or1B) systems. In contrast, parkin failed to associate with
-TrCP, a second F-box/WD protein (Figure 1B). Parkin T240R (ARPD mutant) parkin, as well as either hSel-10
or -TrCP, were transfected along with hemagglutininalso failed to associate with several other WD repeat-
containing proteins (protein phosphatase 2A/B, the  (HA)-tagged ubiquitin into HeLa cells. Flag immunopre-
cipitation from cell lysates and subsequent Westernsubunit of heterotrimeric G protein, and the Cockayne
syndrome subunit A gene product) or F-box proteins blotting for the Flag tag revealed a high molecular weight
smear in lysates from cells transfected with wild-type(Figure 1B and data not shown). Of note, hSel-10 and
parkin are both predominantly cytoplasmic proteins en- (Figure 2A, lane 1) but not T240R mutant parkin (Figure
2A, lane 3), consistent with autoubiquitination of parkin.riched in adult brain (Koepp et al., 2001) (parkin has also
been reported to colocalize with Golgi apparatus and Indeed, Western blots of Flag immunoprecipitates for
HA-ubiquitin (Figure 2B, lane 1) again demonstrated asynaptic markers (Fallon et al., 2001; Kubo et al., 2001).
Cotransfection of Flag-parkin and Myc-tagged UbcH7, high molecular weight smear in lysates from wild-type
parkin-transfected cells, confirming that these speciesfollowed by Flag immunoprecipitation, confirmed the
previously described association of parkin and the E2 are ubiquitinated derivatives of parkin. Overexpression
of hSel-10 dramatically potentiated the ubiquitin ligaseUbcH7 (Figure 1A) (Shimura et al., 2000a), whereas no
such interaction was observed with other E2s including activity of wild-type (Figure 2A, lane 2, and Figure 2B,
lane 2) but not T240R ARPD mutant parkin (Figure 2A,UbcH8 and Ubc6 (data not shown).
Deletion analysis of parkin and hSel-10 in transfected lane 4). In contrast, overexpression of -TrCP (Figure
2A, lane 6) failed to potentiate parkin ubiquitin ligaseHeLa cells revealed that the carboxyl terminus of parkin,
which includes the two RING finger domains, interacts activity. As HeLa cells express endogenous hSel-10
(Koepp et al., 2001), the basal level of parkin ubiqui-specifically with the F-box of hSel-10 (Figures 1C and
1D). Furthermore, a missense mutation in parkin within tination in untransfected HeLa cells may be due to en-
dogenous hSel-10 or a related activity. We thereforethe first RING finger (T240R; Figure 1C), which leads
to a familial ARPD syndrome (Shimura et al., 2000b), cotransfected tagged parkin and ubiquitin expression
constructs, as above, along with deletion mutants ofabrogated the interaction with hSel-10 (Figure 1D), con-
sistent with the notion that this association is important hSel-10 (WD repeat domain alone [WD] and F-box do-
main alone [F-box]) (Strohmaier et al., 2001) that arefor parkin function. A second interaction was apparent
between either full-length or the amino-terminal ubiqui- thought to function in a dominant-negative manner (and
bind to wild-type parkin; Figure 1D and see Supplemen-tin homology domain (UHD) of parkin and the WD repeat
domain of hSel-10, but this interaction was not required tary Data at http://www.neuron.org/cgi/content/full/37/
5/735/DC1). Indeed, overexpression of these hSel-10for parkin-hSel-10 association (Figure 1D and see Sup-
plementary Data at http://www.neuron.org/cgi/content/ mutants inhibited parkin-mediated ubiquitination, indi-
cating that parkin ubiquitin ligase activity requires hSel-full/37/5/735/DC1).
We sought to confirm the interaction between parkin 10 or a related activity in vivo (Figure 2B, lanes 3 and 4).
We further investigated whether the E2 ubiquitin-con-and hSel-10 in mammalian brain extracts. Immunopre-
cipitation of normal human frontal cortex extract with jugating enzyme UbcH7 functions in the above parkin
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Figure 1. Parkin Interacts Specifically with the F-Box/WD Repeat Protein hSel-10
(A) Flag-parkin (52 kDa) was coexpressed with Myc-hSel-10 (69 kDa), Myc-UbcH7 (18 kDa), or PP2A/B (55 kDa) in HeLa cells. Anti-Flag
immunoprecipitates and lysates were probed as indicated by Western blotting. Asterisk indicates the position of immunoglobulin light chain.
(B) Insect cells were coinfected with baculovirus expressing GST-parkin (75 kDa), Flag-hSel-10 (110 kDa form), or Flag--TrCP (65 kDa). GST
pull-downs or anti-Flag immunoprecipitations were performed as described, followed by Western blotting with monoclonal antibodies to either
the Flag tag or the parkin ubiquitin homology domain (see Supplementary Data at http://www.neuron.org/cgi/content/full/37/5/735/DC1).
(C) The primary structure of parkin and hSel-10 showing their major domains.
(D) Either wild-type parkin, ARPD mutant (T240R) parkin, a deletion mutant form of parkin lacking the ubiquitin homology domain (UHD
parkin), or a truncated form of parkin corresponding to its UHD alone (parkinUHD) were coexpressed in HeLa cells with Myc-tagged hSel-10
(wild-type, mutant WD repeat alone [hSel-10WD, 49 kDa], or mutant F-box alone [hSel-10F-box, 35 kDa]). Anti-Myc immunoprecipitates and crude
lysates were analyzed by Western blotting with polyclonal antibodies to Myc or to the carboxyl terminus of parkin. The parkin polyclonal
antibody recognizes both full-length parkin (52 kDa) and a truncated form that is deleted in the UHD (UHD; 42 kDa) and appears to be
generated by posttranslational processing (Schlossmacher et al., 2002) (data not shown).
(E) Homogenates of 1 g frozen frontal cortex from an ARPD case (see Experimental Procedures) or age-matched control were immunoprecipi-
tated with a monoclonal antibody specific for the amino terminus of human parkin (see Supplementary Data at http://www.neuron.org/cgi/
content/full/37/5/735/DC1) and probed for parkin (using this parkin monoclonal antibody), hSel-10, or -synuclein.
(F) Fresh mouse brain (2 g total) homogenates were incubated with immobilized recombinant Flag-hSel-10 (110 kDa; the 69 and 110 kDa
forms of hSel-10 both contain the F-box and WD repeat domains) (Koepp et al., 2001) or Flag--TrCP produced in insect cells. Complexes
were Flag immunoprecipitated and probed by Western blotting for cyclin E (51 kDa) or parkin (using parkin monoclonal antibody). Asterisk
indicates the position of immunoglobulin heavy chain.
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Figure 2. HSel-10 and UbcH7 Function Co-
operatively to Potentiate Parkin Ubiquitin Li-
gase Activity
(A) Plasmids encoding Flag-WT or T240R
ARPD parkin were cotransfected with or with-
out hSel-10 (69 kDa) into HeLa cells, and cells
were subsequently treated with lactacystin to
inhibit proteasome function. Cell lysates were
immunoprecipitated with an anti-Flag anti-
body and probed by Western blotting.
(B) Flag-parkin and HA-ubiquitin were cotrans-
fected in HeLa cells along with full-length
hSel-10 (69 kDa), hSel-10WD, hSel-10F-box,
-TrCP, or vector. Lysates were immunopre-
cipitated with anti-Flag antibody, and ubiqui-
tinated species were detected by Western
blotting with an anti-HA antibody. Lumines-
cence exposure time was extended in (B) rel-
ative to the other panels (compare [B], lane
1, to [C], lane 1) to allow for detection of the
lower levels of autoubiquitination observed
in the presence of mutant forms of hSel-10.
(C and D) Plasmids encoding Flag-parkin,
hSel-10, ubiquitin, UbcH7, or UbcH8 were co-
transfected in the combinations indicated,
and ubiquitinated species were detected as
above.
ubiquitination assay by cotransfecting a UbcH7 expres- the T240R ARPD parkin mutation attenuated the associ-
ation of parkin with Cul1 (see Supplementary Data atsion construct. Consistent with the protein interaction
data (Figure 1A), we found that overexpression of UbcH7 http://www.neuron.org/cgi/content/full/37/5/735/DC1).
To investigate the relationship of the parkin-hSel-10(Figure 2C, lane 3) but not UbcH8 (Figure 2C, lane 4)
or Ubc6 (data not shown) increased parkin-mediated complex with the SCFhSel-10 complex, we went on to per-
form a pull-down of His6-Skp1 from the insect cell ly-ubiquitination. Furthermore, the enhancement of parkin-
mediated ubiquitination by UbcH7 overexpression re- sates. Tagged Skp1 copurified Cul1, hSel-10, and Rbx1
from insect cells (the SCFhSel-10 complex) (Koepp et al.,quired coexpression of hSel-10 (Figure 2D, lanes 3 and
4). Thus, parkin functions cooperatively with hSel-10 2001; Strohmaier et al., 2001), but not parkin (Figure 3B,
right panel). Flag immunoprecipitation of hSel-10, asand UbcH7.
expected, coprecipitated parkin as well as all of the SCF
components (see Supplementary Data at http://w w w .A Parkin-HSel-10-Cullin-1 Complex
HSel-10 has been shown to function in cell cycle regula- neuron. org/cgi/content/full/37/5/735/DC1). Taken
together, these data show that the parkin-hSel-10-Cul1tion within a modular, multiprotein E3 ubiquitin ligase
complex termed the SCFhSel-10 complex (for Skp1, Cullin, complex is cooperative and distinct from the SCFhSel-10
complex. We next sought to confirm the presence ofand F-box) (Patton et al., 1998; Skowyra et al., 1997)
that includes Rbx1, a RING domain protein (Kamura et the parkin-hSel-10-Cul1 complex in brain extracts. Im-
munoprecipitation of normal human frontal cortex brainal., 1999; Skowyra et al., 1999). We therefore speculated
that other characterized SCFhSel-10 components might be extract (but not parkin-deficient ARPD frontal cortex
extract) with a parkin-specific antibody copurified Cul1present in the parkin-hSel-10 complex. To investigate
this possibility, we coexpressed tagged parkin with but not Skp1 or Rbx1 (Figure 3C), consistent with the
above data. Thus, parkin associates cooperatively withtagged forms of Cul1, Skp1, and Rbx1 in HeLa and insect
cells. Subsequent pull-down assays revealed that parkin Cul1 and hSel-10 in a novel complex that is distinct from
SCFhSel-10.associates with Cul1, but not Skp1 or Rbx1 (Figures
3A and 3B). The parkin-Cul1 interaction appears to be
modified by hSel-10, as the interaction is potentiated in Ubiquitination of Cyclin E by Parkin
HSel-10 functions as an adaptor to recruit specific sub-HeLa cells that overexpress hSel-10 (Figure 3A), and as
parkin failed to associate with Cul1 in insect cells in the strates for ubiquitination by the SCFhSel-10 complex, in-
cluding cyclin E, a regulatory subunit of cyclin-depen-absence of hSel-10 (Figure 3B, left panel). Furthermore,
Parkin Complex and Excitotoxicity
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Figure 3. Parkin Associates with Cul1 but
Not with Skp1 or Rbx1
(A) HeLa cells were transiently transfected
with expression constructs encoding Flag-
parkin, HA-Cul1 (86 kDa), and His6-Skp1 (19
kDa) in the presence or absence of Myc-hSel-
10 (69 kDa). Lysates were immunoprecipi-
tated with anti-Flag antibodies and probed
by Western blotting as indicated.
(B) Left panel: insect cells were coinfected
with baculoviruses expressing GST-parkin,
HA-Cul1, His6-Skp1, Rbx1 (11 kDa), and either
Flag-hSel-10 (110 kDa) or Flag--TrCP. GST-
parkin was pulled down with Sepharose glu-
tathione beads, and complexes were probed
by Western blotting. Right panel: insect cells
were infected as above, with or without His6-
Skp1. Skp1-associated complexes were iso-
lated from cell lysates by nickel-agarose pull-
downs and analyzed by Western blotting.
(C) Homogenates of 1 g frozen frontal cortex
from an ARPD case or an age-matched con-
trol were immunoprecipitated with a mono-
clonal antibody specific for parkin and
probed as indicated by Western blotting.
Western analysis of parkin and hSel-10 is
shown in Figure 1E.
dent kinase 2 (CDK2) (Ekholm and Reed, 2000). cation by a parkin-hSel-10-Cul1 E3 complex. Of note,
cullins, including Cul1, have been implicated directly inUbiquitination and degradation of phosphorylated cy-
clin E by the SCFhSel-10 complex underlies the regulation the ubiquitination of cyclin E (Dealy et al., 1999; Singer
et al., 1999). Thus, we further hypothesized that theof cell cycle entry into S phase. Interestingly, hSel-10
(Strohmaier et al., 2001) is highly expressed in adult parkin-hSel-10-Cul1 E3 complex may target cyclin E and
that parkin-associated ARPD may lead to toxic accumu-brain neurons, consistent with a role in postmitotic cells.
Of note, the accumulation of cyclins, including cyclin E, lation of this substrate.
We first tested the hypothesis that hSel-10 could re-has been implicated in the regulation of apoptosis in
postmitotic neurons, as increased cyclin levels correlate cruit cyclin E to a parkin-associated complex. Insect
cells were infected with baculoviruses encoding GST-with apoptosis (Verdaguer et al., 2002) and cyclin depen-
dent-kinase (CDK) inhibitors prevent such neuronal parkin, Flag-hSel-10 (or Flag--TrCP), and His6-cyclin E
(or His6-cyclin A1), and HA-Cdk2 (which stabilizes phos-death (Copani et al., 2001; Liu and Greene, 2001; Padma-
nabhan et al., 1999; Park et al., 1998). Furthermore, phorylated forms of cyclin E that interact with hSel-10
[Clurman et al., 1996]). Cell lysates were subsequentlycyclin and CDK levels are increased in neurons in the
course of several neurodegenerative disorders such as analyzed by pull-down assays and Western blotting.
These studies confirmed that cyclin E (Figure 4A, lanePD (Chung et al., 2001a; Husseman et al., 2000). We
hypothesized that hSel-10 may recruit cyclin E to the 1) but not cyclin A1 (lane 2), could be recruited to a
parkin-associated complex by hSel-10 (Figure 4A, lanesparkin-hSel-10-Cul1 complex in postmitotic neurons in
a manner that is analogous to its role as an adaptor in 1 and 3), but not by -TrCP (Figure 4A, lane 4).
We sought to determine whether a parkin-associatedSCFhSel-10. As hSel-10 is known to bind directly to cyclin
E, it may recruit cyclin E and other substrates for modifi- complex is able to ubiquitinate cyclin E substrate in
Neuron
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Figure 4. Cyclin E Is a Candidate Substrate of the Parkin/Cul1/hSel-10 Ubiquitin Ligase Complex
(A) Insect cells were coinfected with baculoviruses expressing Flag-hSel-10 (110 kDa) or Flag--TrCP, GST-parkin, HA-Cdk2, and either His6-
cyclin E or His6-cyclin A1 (50 kDa). Cyclin E- or cyclin A1-associated complexes were isolated from cell lysates by nickel-agarose pull-downs
and analyzed by Western blotting as indicated.
(B) Flag-parkin-associated complexes (immunoprecipated from HeLa cells transfected with Flag-tagged wild type or T240R mutant parkin)
were incubated with recombinant His6-cyclin E, HA-Cdk2, E1, UbcH7, and ubiquitin, in the presence of an ATP-regenerating system. Recombi-
nant His6-cyclin E generated in insect cells appears as a 51 kDa band (arrow) and a minor contaminating species at 95-kDa. Asterisk indicates
the position of immunoglobulin heavy chain.
(C) Parkin deficiency leads to cyclin E accumulation. Dissociated cortical neurons from E16.5 mice were cultured as described (see Experimental
Procedures), transfected with 25 nM parkin siRNA or control (DAT) siRNA, and then treated for 24 hours with 500 M kainate. After 48 hours,
cells were extracted with loading buffer, and lysates were probed by Western blotting for parkin, cyclin E, -actin, and cleaved PARP. The
asterisk indicates a nonspecific band; the arrow indicates the position of parkin (52 kDa). Densitometric analysis of protein bands (NIH Image
1.62) and relative band intensities are presented as the mean  SEM of three independent measurements. *p  0.01, Student’s t test.
(D) Homogenates of substantia nigra (SN) tissue from ARPD brain, age-matched control, two sporadic PD cases, and two sporadic AD cases
were probed by Western blotting for parkin, cyclin E, UbcH7, or cyclin D1 (35 kDa).
vitro. We found that Flag-immunoprecipitated, wild-type tination components in vitro (Figure 4B, lanes 3, 5, and
7), whereas T240R ARPD mutant parkin complex failedparkin-associated complex (from lysates of Hela cells
transfected with Flag-parkin) could modify recombinant to do so (Figure 4B, lane 4). Furthermore, cyclin E ubiqui-
tination appeared phosphorylation dependent, as pre-cyclin E/CDK2 substrate in the presence of other ubiqui-
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treatment of the substrate with -phosphatase inhibited ule cells, as these cells are readily purified to near homo-
geneity (Scheiffele et al., 2000) and appear to be devoidthe modification (Figure 4B, lanes 6 and 7).
of endogenous parkin expression (see Figure 5A). Fur-
thermore, cyclin E has been shown to accumulate withParkin Deficiency Potentiates the Accumulation
apoptosis in such cultures (Padmanabhan et al., 1999;of Cyclin E
Verdaguer et al., 2002). Granule neurons transfectedWe hypothesized that parkin deficiency would potenti-
with a bicistronic expression plasmid encoding wild-ate the accumulation of cyclin E in primary neurons.
type parkin or vector alone (along with green fluorescentPrevious studies have indicated that primary neuronal
protein [GFP]) were treated with kainate (500 M for 24cultures accumulate cyclin E in response to the gluta-
hr). Subsequently, cultures were analyzed by Westernmatergic excitotoxin kainate (Padmanabhan et al., 1999;
blotting or immunofluorescence microscopy. As pre-Verdaguer et al., 2002), and we confirmed this to be
viously described, kainate treatment led to the accumu-the case for primary cortical, cerebellar granule, and
lation of cyclin E in granule cell cultures (Figures 5A, 5B,midbrain neuron cultures (see below, and data not
5E, 5H, and 5H). Furthermore, overexpression of parkinshown). To investigate the role of parkin in the accumula-
significantly attenuated the accumulation of cyclin Etion of cyclin E, primary cortical cultures (prepared from
(Figures 5H, 5H, 5K, and 5K). Analysis of cyclin E mRNAembryonic day 16.5 [E16.5] embryos) were transfected
by quantitative real-time PCR indicated that the accumula-with 25 nM parkin-specific or control (dopamine trans-
tion of cyclin E protein was not accounted for by differ-porter-specific) short interfering RNAs (siRNAs) (Elbashir
ences in cyclin E mRNA (see Supplementary Data at http://et al., 2001) and subsequently treated with kainate.
www.neuron.org/cgi/content/full/37/5/735/DC1).Western analysis of lysates from cultures transfected
with control siRNA revealed readily detectable parkin
protein expression (Figure 4C), whereas lysates from Parkin Overexpression Protects Postmitotic
Neurons from Kainate-Mediated Excitotoxicityparkin siRNA-transfected cultures displayed signifi-
cantly reduced parkin expression. As predicted, parkin- Cell cycle regulatory proteins have been implicated in
the apoptotic death of postmitotic cells. Cyclins, includ-deficient cultures displayed increased accumulation of
cyclin E (Figure 4C). Furthermore, such cultures dis- ing cyclin E, accumulate in postmitotic cells destined
for apoptosis, whereas inhibitors of cyclin-dependentplayed accumulation of cleaved poly (ADP-ribose) poly-
merase (cleaved-PARP), a marker of apoptosis. kinases block apoptosis (Copani et al., 2001; Liu and
Greene, 2001; Padmanabhan et al., 1999; Park et al.,Parkin deficiency leads to neuronal loss in ARPD, and
PD has been associated with apoptotic neuronal death 1998). In contrast to cyclin E regulation at the G1/S cell
cycle checkpoint, little is known about the regulation of(Burke and Kholodilov, 1998). We therefore next investi-
gated whether cyclin E is accumulated in extracts from cyclin E accumulation in postmitotic cells. Based on the
data above, we hypothesized that parkin may play aparkin-deficient human ARPD brain. Western blotting
with a specific antibody demonstrated accumulation of role in the regulation of cyclin E in the context of neuronal
apoptosis and that parkin overexpression would protectcyclin E in substantia nigra from ARPD brain tissue ex-
tract relative to age-matched control extract (Figure 4D). postmitotic neurons from cell death.
As described above, cyclin E is upregulated in theIn contrast, no accumulation was observed for three
other proteins: cyclin D1, UbcH7, or -synuclein (Figure course of kainate-induced apoptosis of cultured cere-
bellar granule cells, and overexpression of parkin4D, and data not shown). Similar accumulation of cyclin
E was observed in frontal cortex extract from ARPD attenuates the accumulation of cyclin E. To investigate
whether parkin overexpression would protect thesebrain as well as in cortical extracts from three indepen-
dent ARPD cases relative to three normal controls cells from apoptosis, granule neurons were transfected
and treated with kainate as above. Apoptosis was quanti-(J.F.S., A.A., and N. Hattori, unpublished data). Analysis
of cyclin E mRNA by quantitative real-time PCR indi- fied by visualization of condensed nuclei using Hoechst
staining and fluorescence microscopy (Figure 6). Neu-cated that the accumulation of cyclin E protein was not
accounted for by differences in cyclin E mRNA transcript ronal cultures transfected with parkin showed signifi-
cantly fewer apoptotic nuclei than vector-transfectedlevels (see Supplementary Data at http://www.neuron.
org/cgi/content/full/37/5/735/DC1). Analysis of cyclin E cells (Figure 6). Thus, parkin overexpression can protect
postmitotic neurons from toxin-mediated apoptosis,protein accumulation in substantia nigra extracts from
sporadic PD and AD cases similarly demonstrated the and this may be a consequence of inhibiting cyclin E
accumulation.accumulation of cyclin E in sporadic PD but not sporadic
AD nigral extracts (Figure 4D), consistent with the notion
that cyclin E accumulation may be relevant to sporadic Parkin and Dopamine Neuron Survival
PD as well as parkin-associated ARPD. Finally, analysis ARPD and sporadic PD lead to the relatively specific
of frontal cortex extracts from sporadic PD (relative to loss of dopamine neurons, although additional neuronal
AD, Huntington’s disease, and normal control) brains populations are affected to a variable extent. Further-
revealed a variable degree of cyclin E accumulation more, glutamate excitotoxicity has been implicated as
(J.F.S. and A.A., unpublished data). a potential mechanism for dopamine neuron loss in PD
(LBs) (Lang and Lozano, 1998; Olanow and Tatton,
1999). As described above, parkin deficiency leads toParkin Overexpression Inhibits the Accumulation
of Cyclin E increased cyclin E accumulation and the expression of
apoptotic markers in the context of an excitotoxic insultWe investigated the effect of parkin overexpression on
kainate-induced apoptosis of cultured cerebellar gran- to primary neurons, whereas parkin overexpression pro-
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Figure 5. Parkin Overexpression Attenuates
the Accumulation of Cyclin E in Kainate-
Treated Cells
Cerebellar granule cells from postnatal day 6
(P6) mice were transfected in suspension with
a bicistronic expression plasmid for wild-type
parkin (along with GFP) or vector (GFP alone),
cultured at a density of 75,000 cells/cm2 for
72 hours, and then treated with or without
500 M kainate for 24 hours.
(A) Cells were extracted directly with loading
buffer, and lysates were analyzed by Western
blotting as indicated.
(B–M) Granule cell cultures were fixed,
stained with a specific antibody against
cyclin E, and then visualized by fluorescence
microscopy for cyclin E (red) and GFP (green).
Arrows indicate Parkin-transfected neurons
that display reduced accumulation of cyclin
E relative to surrounding untransfected neu-
rons (K and K) or neurons transfected with
vector (H and H). Scale bar, 50 m.
tects primary neurons. We sought to extend these stud- excitotoxicity. Parkin siRNA treatment alone, in the ab-
sence of kainate, failed to alter cyclin E or DAT immuno-ies to primary dopamine neuron cultures. Embryonic
day 13.5 (E13.5) primary culture midbrain dopamine neu- reactivity (Figure 7U–7X), and thus parkin “knockdown”
is not directly toxic but appears to sensitize neurons torons, identified by immunohistochemical staining for the
dopamine transporter (DAT) (Nirenberg et al., 1996), kainate excitotoxicity.
Parkin siRNA treatment failed to alter dopamine neu-were transfected with parkin siRNA (Figures 7F–7J and
7P–7T) or control siRNA (Figures 7A–7E and 7K–7O) and ron sensitivity to 1-methyl-4-phenylpyridinium (MPP	;
10 M) at a toxin dose that (in control siRNA-treatedsubsequently exposed to kainate, as above. As predicted,
parkin “knockdown” dopamine neurons displayed in- cultures) led to a reduction in DAT immunoreactivity
comparable to the kainate treatment (Figure 7X). Wecreased accumulation of cyclin E (Figure 7S) and in-
creased apoptosis (Figures 7J and 7T) versus control further investigated the effect of parkin “knockdown”
on the kainate sensitivity of DAT-negative neurons insiRNA-treated cells. Furthermore, parkin siRNA-treated
midbrain cultures displayed decreased DAT immunore- midbrain cultures, which are primarily GABAergic
(greater than 90%; J.F.S. and A.A., unpublished data),activity in cell bodies and processes in the presence of
kainate (compared to control siRNA-treated cells; Figure in order to determine the specificity of parkin action.
Parkin siRNA did sensitize DAT-negative neurons to kai-7I), consistent with the increased sensitivity to kainate
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Figure 6. Parkin Protects Postmitotic Neurons from Kainate-Mediated Toxicity
Cerebellar granule cells from P6 mice were transfected as in Figure 6 and then cultured in the presence or absence of kainate for 24 hours
with 500 M kainate.
(A–L) Cells were stained for 20 min with 0.5 g/ml Hoechst dye, and apoptotic nuclei were visualized by fluorescence microscopy. Arrows
point to transfected apoptotic neurons apparent in the vector-only transfected cultures (K) but not the parkin-transfected culture (L). Scale
bar, 100 m.
(M) Cell protection in the absence or presence of kainate is expressed as a percentage of GFP-positive (transfected) cells that are also
Hoechst positive (apoptotic). Data are shown as the mean  SEM for two independent experiments performed in triplicate. Statistical
significance was assessed using one-way ANOVA with Tukey-Kramer post hoc tests between each group. *p  0.005.
nate toxicity, but to a significantly lesser extent than it E13.5 midbrain dopamine neuron cultures; see Experi-
mental Procedures) conferred robust protection of do-did the DAT-positive population with respect to cyclin
E induction and apoptosis (p  0.05 for both measures; paminergic cell bodies and processes from 250 M kai-
nate, as quantified by DAT immunohistochemistrysee Supplementary Figures S2B–S2D at http://www.
neuron. org/cgi/content/full/37/5/735/DC1). Thus, (Figure 8; as compared to control lentivirus). Both parkin
and control viruses infected over 90% of DAT-positiveparkin deficiency appears to preferentially sensitize
midbrain dopamine neurons to kainate excitotoxicity. neurons (see Supplementary Data at http://www.neuron.
org/cgi/content/full/37/5/735/DC1, and data not shown).Overexpression of parkin using a lentiviral vector (in
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Figure 7. Parkin Deficiency Potentiates Kainate-Mediated Toxicity in Midbrain Dopamine Neurons
Dissociated midbrain cultures from E13.5 mice were prepared as described (see Experimental Procedures), transfected with 25 nM parkin or
control (SERT) siRNA, and treated for 24 hours with 250 M kainate (A–X) or 1 M MPP	 (U–X). Cells were treated with Hoechst dye, fixed,
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Figure 8. Parkin Overexpression Protects Midbrain Dopamine Neurons from Kainate-Mediated Toxicity
Primary E13.5 midbrain cultures were prepared as above, infected with human parkin or control (GFP) lentiviral vectors (see Experimental
Procedures), and subsequently cultured for 24 hours with (G–L) or without (A–F) 250 M kainate. Cultures were subsequently fixed and stained
with a monoclonal antibody specific for human parkin (which is not cross-reactive with the endogenous mouse parkin, see Supplementary
Data at http://www.neuron.org/cgi/content/full/37/5/735/DC1) and a rat monoclonal antibody against DAT. Arrow points to an example of a
GFP-infected, kainate-treated, DAT-positive neuron with diminished DAT immunoreactivity. Total DAT-specific immunonoreactivity (pixels)
across nine fields of view at 20
 was quantified in triplicate as in Figure 7. Data are shown as the mean  SEM. Statistical significance was
assessed using one-way ANOVA with Tukey-Kramer post hoc tests between each group; *p  0.01. Scale bar, 150 m.
Parkin overexpression did not appear to alter sensitivity Discussion
to MPP	 (see Supplementary Figure S3 at http://www.
neuron.org/cgi/content/full/37/5/735/DC1). Furthermore, Parkin associates with hSel-10 and Cul1 in a novel ubi-
quitin ligase complex. The parkin ubiquitin ligase com-parkin overexpression did not alter DAT immunoreactiv-
ity in primary midbrain neuron cultures in the absence plex functions in parkin autoubiquitination as well as
heteroubiquitination of cyclin E. We hypothesize that,of toxin (Figure 8M).
and stained with rabbit polyclonal antibodies against either mouse parkin or cyclin E (green) and a rat monoclonal antibody against DAT (red).
Immunostaining and apoptotic nuclei were visualized by fluorescence microscopy. Arrows point to examples of DAT-positive cyclin E-positive
neurons (S) and DAT-positive neurons with apoptotic (Hoechst-positive) nuclei (I, J, and T). Total DAT-specific immunonoreactivity (pixels)
across nine fields of view at 20
 was quantified in triplicate using Image software (Scion). Cytoplasmic parkin and cyclin E immunoreactivity
(mean pixel density) in DAT-positive neurons were quantified similarly. Data are shown as the mean  SEM. Statistical significance was
assessed using one-way ANOVA with Tukey-Kramer post hoc tests between each group. *p  0.01. Scale bar, 150 m.
Neuron
746
in addition to cyclin E, there are additional targets of rons) to kainate excititoxicity, as may be the case in
parkin ubiquitination, as other characterized RING fin- parkin-associated ARPD. Parkin overexpression did not
ger-associated E3 complexes appear to target multiple appear to protect cultured primary dopamine neurons
diverse substrates (Joazeiro and Weissman, 2000). We from MPP	 toxicity, and parkin knockdown (with siRNA)
cannot exclude the possibility that cyclin E is not a did not appear to sensitize dopamine neurons to MPP	
relevant target for parkin complex in ARPD, but we pre- (at least under the conditions used here). These data
sent evidence that parkin does appear to regulate cyclin suggest that different mechanisms may underlie kainate
E in the course of neuronal apoptosis, in dopamine neu- and MPP	-mediated toxicity, and indeed it has been
rons, and in ARPD tissue. What other substrates might reported that MPP	 treatment induces nonapoptotic
be targeted by the parkin complex activity? Of interest, death in neuronal midbrain cultures (Lotharius et al.,
genetic and biochemical evidence implicate hSel-10 in 1999), in contrast with kainate. In a recent report (Petru-
the ubiquitination of Notch4 (Wu et al., 2001) and presen- celli et al., 2002), parkin overexpression was found to
ilin (Wu et al., 1998), the latter of which is mutated in protect primary midbrain catecholaminergic neurons
autosomal dominant forms of Alzheimer’s disease. from nonapoptotic death associated with the overexpres-
Thus, these represent additional candidates for parkin sion of mutant -synuclein or proteasomal inhibition.
complex activity. Although the molecular mechanism of this protection
SCF complexes are modular: for instance, Skp1 can remains unclear, it appears to differ from that underlying
interact with several F-box adaptor proteins, thereby the protection of primary neurons from excitotoxin-
generating functional diversity. It is of interest to deter- mediated apoptotic death described in our report.
mine whether parkin associates with adaptor proteins Finally, we note that the protective role of parkin over-
other than hSel-10 (although we failed to detect an inter- expression suggests a potential treatment approach for
action with other F-box/WD repeat proteins in this PD and other diseases that relate to glutamate excito-
study), as such complexes would likely display different toxicity. Thus, further understanding of the parkin ubi-
substrate specificities. This may explain the diverse tar- quitin ligase complex and its mechanism of action may
gets that have been reported for parkin, including lead to novel diagnostic and therapeutic tools.
CDCrel-1 (Zhang et al., 2000), synphilin-1 (Chung et al.,
2001b), PAEL-R (Imai et al., 2001), and a modified form
Experimental Proceduresof -synuclein (Sp22) (Shimura et al., 2001). Recently,
parkin has been reported to form a complex with the
Expression Vectors, Cell Culture, and Antibodiesheat shock protein Hsp70 as well as CHIP, an Hsp70-
cDNAs for parkin, UbcH7, -synuclein, and UbcH8 were PCR ampli-
associated protein with E3 activity, in SH-SY5Ycells that fied from a human liver cDNA library (Clontech) and cloned into the
overexpress parkin (Imai et al., 2002). It remains to be eukaryotic expression vector pCMS-EGFP (Clontech) or pcDNA3.1.
determined whether SCF-like components play a role Flag-parkin, T240R parkin, Flag-T240R parkin, and UHD parkin,
were generated by PCR-mediated mutagenesis. A cDNA clone en-in this complex.
conding PP2A/B was obtained from Research Genetics. HSel-10Our data support the notion that there is both redun-
constructs have been described (Wu et al., 2001). The integrity of alldancy and specificity in the regulation of cyclin E (Koepp
constructs was confirmed by automated sequencing. Recombinantet al., 2001; Winston et al., 1999). Although cyclin E
baculoviruses expressing GST-tagged parkin was generated using
accumulation has been noted in the context of several the Baculogold system (Pharmingen) as per the manufacturer’s in-
apoptosis model systems, the mechanism of regulation structions.
of cyclin E in neuronal apoptosis has not previously HeLa cells were maintained in Dulbecco’s modified Eagle medium
been investigated. The data presented here suggest that (Life Technologies) supplemented with 10% fetal bovine serum (Life
Technologies) heat inactivated for 30 min at 50C. Cells were trans-parkin regulates the degradation of cyclin E in the con-
fected using Lipofectamine Plus (Life Technologies), incubated fortext of neuronal apoptosis. Furthermore, as the parkin
24–36 hr, and treated as appropriate with 2.5 M lactacystin (Sigma)ubiquitin ligase complex targets cyclin E, this effect is
for 16 hr. Baculovirus expression and protein purifications werelikely to be direct. It has been suggested that cyclin E
performed as described (Carrano et al., 1999).
accumulation in apoptotic neurons may represent an A parkin lentiviral vector was assembled by cloning the human
attempt at cell cycle reentry (Verdaguer et al., 2002); parkin cDNA into the BamH1 and XhoI restriction enzyme sites of
alternatively, apoptosis and cell cycle regulation may plasmid pTRIP GFP, replacing the GFP gene (Zennou et al., 2001).
Parkin and control GFP viruses were produced by cotransfectionshare similar intracellular pathways.
of 293T cells with p8.91 and pHCMV-G, and viral transduction ofCyclin regulation, and specifically cyclin E, has pre-
neuronal cultures was performed as described (Zennou et al., 2001).viously been implicated in kainate excitotoxin-induced
Parkin and cleaved-PARP polyclonal antibodies were obtainedneuronal apoptosis (Padmanabhan et al., 1999; Verda-
from Cell Signaling; -synuclein, UbH7, and Skp1 monoclonal anti-
guer et al., 2002). We show that parkin overexpression bodies, from Transduction Labs; monoclonal rat antibody against
protects dopamine neurons from kainate-mediated apo- DAT and polyclonal rabbit antibodies against PP2A-B and GAD-
ptosis, that parkin knockdown (using siRNA) sensitizes 65, from Chemicon; HA polyclonal antibody, from Clontech; HRP-
dopamine neurons to such excitotoxicity and that this coupled Flag monoclonal antibody, from Sigma; Myc polyclonal,
cyclin D1 polyclonal, cyclin A1 polyclonal, and cyclin E monoclonalcorrelates with the accumulation of cyclin E. We note
and polyclonal antibodies, from Santa Cruz; Cul1 and Rbx1 poly-that glutamate excitotoxicity has been implicated in spo-
clonal antibodies from Zymed; and hSel-10 (69 kDa form) polyclonalradic PD (Olanow and Tatton, 1999; Schulz et al., 1997),
antibody from Gentaur Molecular Products. Mouse monoclonal anti-and excitatory input ablation appears to protect dopa-
body 2E10 against recombinant human parkin was generated using
mine neurons (Klein et al., 2002; Olanow and Tatton, standard techniques (Ericson et al., 1996). HRP-coupled goat anti-
1999; Raina et al., 2000; Takada et al., 2000). Parkin mouse and goat anti-rabbit secondary antibodies were obtained
deficiency appeared to preferentially sensitize midbrain from Jackson Immunoresearch. Fluorescently labeled secondary
antibodies were obtained from Molecular Probes.dopamine neurons (versus midbrain GABAergic neu-
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Immunoprecipitation, Western Blot, and mRNA Analysis antibody generation; Alan Weissman for plasmids encoding Ubc6
and Ubc7; P. Charneau and V. Zennou for lentiviral vectors; PeterTransiently transfected HeLa cells were suspended in lysis buffer
(50 mM Tris [pH 7.6], 150 mM NaCl, 0.2% Triton X-100, and complete Scheiffele for assistance with cerebellar granule neuron cultures;
Jim Goldman, Jean-Paul Vonsattel, and Steve Chin for assistanceprotease inhibitors [Sigma]), incubated for 60 min at 4C, and cleared
by centrifugation at 20,000 
 g for 15 min at 4C. Samples used with banked tissue; and members of the Shelanski, Greene, and
Liem labs for reagents and technical assistance. Funding was ob-for in vivo ubiquitination assays were suspended in lysis buffer
supplemented with 2.5 mM N-ethyl maleimide (NEM), and lysates tained from the Taub and Rockefeller Brothers Foundations (A.A.)
and ALSAC (B.S.). A.A. is a Beeson and Culpeper scholar.were subsequently quenched with 2.5 mM DTT for 20 min at 4C.
Immunoprecipitations and Western blotting were performed using
standard techniques (Wu et al., 2001). Human brain tissue was ob- Received: August 22, 2002
tained from the Columbia University Alzheimer’s Disease Research Revised: January 21, 2003
Center Brain Bank. Quantitative real-time PCR was performed as
described (Troy et al., 2001) using primers specific for cyclin E and References
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